Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein
Jiangchao Xiang(ShanghaiTech University), Bei Yang(ShanghaiTech University), Youwei Xu(Chinese Academy of Sciences), Sachdev S. Sidhu(University of Waterloo), Jie Su(Inner Mongolia Agricultural University), Qiaoshuai Lan(Chinese University of Hong Kong), Shuai Xia(Shanghai Medical College of Fudan University), Qilian Qi(ShanghaiTech University), Lu Lu(Shanghai Medical College of Fudan University), Jun Niu(Qilu Hospital of Shandong University), Yu Zhou(Yangtze University), Wenwen Zhao, Shane Miersch(Chrono Therapeutics (United States))
Cited by 14
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
|RePEc: Research Papers in Economics|0|647
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
|Nature Communications|2014|400
The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin
|Signal Transduction and Targeted Therapy|2020|363